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Introduction: The objective of this study was to identify biomarkers of sepsis-induced disseminated intravascular
coagulation (DIC) among platelet-derived factors using biotin label-based custom protein microarray technology in
a mouse cecal ligation and puncture (CLP) model.
Methods: KM mice were randomized into sham-operated and CLP groups. Blood samples were obtained immediately
and at 1 h, 2 h, 6 h, 12 h, 24 h, 48 h and 72 h after establishment of the CLP for platelet count, coagulation assay and
blood chemistry. Lung and mesentery tissues were examined histologically at all corresponding time points, looking
for microthrombus formation. Serial protein microarray analysis was performed to detect platelet-derived factors.
Results: The survival rate 72 h post-CLP was 15%, but there was no mortality among the sham-operated mice.
Compared with the sham group, the platelet count (n = 5, p < 0.05), fibrinogen concentration (n = 5, p < 0.05) and
alanine aminotransferase level of the CLP group began to decrease significantly at 6 h post-CLP. Significant
prolongation of prothrombin time (n = 5, p < 0.05) and activated partial thromboplastin time (n = 5, p < 0.05) and
elevation of D-dimer (n = 5, p < 0.05) occurred after 6 h post-CLP. On histology, microthrombus formation in lung and
mesentery tissue was observed in the CLP groups 6 h post-CLP and had become significant and extensive 12 h post-
CLP (n = 5, p < 0.05). On protein microarray analysis and ELISA, thrombospondin (TSP), tissue inhibitor of
metalloproteinase 1 (TIMP-1) and thymus chemokine-1 (TCK-1) all increased during the first 2 h post-CLP, then
remained at a higher level than in the sham group for 72 h post-CLP (n = 5, p < 0.05).
Conclusions: TSP, TIMP-1 and TCK-1 are elevated in the early stage of sepsis-induced DIC in a mouse CLP model and
may be considered early markers for sepsis-induced DIC.
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Platelet-derived factorIntroduction
Severe sepsis remains a serious problem worldwide, with
intensive care unit death rates ranging between 30% and
70% even under the best of care [1-4]. Sepsis generally
results from the release of cytokines and the activation
of plasma protein cascades such as the coagulation and* Correspondence: linzhaofen@sina.com; chenziliczl@yahoo.com.cn
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reproduction in any medium, provided the orfibrinolytic systems [5-7]. Disseminated intravascular
coagulation (DIC) is a complex syndrome characterized
by activation of the haemostatic and fibrinolytic systems
with increasing loss of localization and compensated
control [8]. DIC is a common complication of sepsis and
is associated with a poor outcome [9-11]. Within this
process, activation of coagulation, inhibition of fibrinolysis
and consumption of coagulation inhibitors lead to a pro-
coagulant state resulting in inadequate fibrin removal and
fibrin deposition in the microvasculature [12]. Eventually,
diffuse obstruction of the microvascular bed gives rise totd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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acute respiratory distress syndrome, hypotension and
circulatory failure. Because of consumption of coagulation
factors and the interference of fibrin degradation products,
diffuse bleeding may occur [13].
Early warning signs of DIC are often nonspecific and
subtle, but the clinical course may be alarmingly fulmin-
ant, leading to death within days of onset. Thus, early
identification of sepsis-induced DIC is a major diagnostic
problem. In 2001, an International Society of Thrombosis
and Haemostasis (ISTH) subcommittee divided DIC into
two stages: non-overt DIC with a stressed but compensated
haemostatic system; and overt DIC with a stressed and
uncompensated haemostatic system [14]. On this basis, a
scoring system for overt DIC was proposed by the ISTH,
using which overt DIC can be diagnosed in 25% in patients
with sepsis [15,16]. However, these diagnostic algorithms
remain far from gold standard [17,18].
Much basic and clinical research has been focused on
the crossroads of coagulation and inflammatory pathways
that is important in the pathogenesis of sepsis and DIC
[19,20]. As key factors in coagulation and immune media-
tors, platelets not only “plug the leak” in a damaged vessel,
but also secrete chemokines and proinflammatory cyto-
kines essential for host defense against microbial infection
[21-23]. Regarding the pathogenesis of sepsis-induced DIC,
these platelet-derived factors warrant research into their
use for early diagnosis and prediction of outcome [24,25].
To identify valuable diagnostic biomarkers of sepsis-
induced DIC among various platelet-derived factors, a
protein microarray kit was customized for use with a
mouse cecal ligation and puncture (CLP) model. Platelet-
derived factors were detected by protein microarray analysis
at different times up to 72 h after establishment of the CLP
model. We report here the development of DIC in the
experimental mice and the identification biomarkers
predictive of the early stage of sepsis-induced DIC.
Materials and methods
Animals
Male Kunming mice (3–4 weeks of age, 19–21 g/body
weight) were obtained from the Experimental Animals
Center of the Second Military Medical University
(Shanghai, China) and maintained under pathogen-free
conditions at a room temperature of 23±3°C and air
humidity of 55±15% in a 12 h light/12 h dark cycle. The
experimental protocols were approved by the Committee
of Animal Experimentation of the Second Military
Medical University.
Anesthesia and CLP Surgery
Mice were subjected to the CLP procedure [26]. They
were not fasted the night before surgery. Briefly, the
mice were anesthetized with 2% sodium phenobarbital(50 mg/kg i.p.) (Sigma, USA). Following a 1 cm midline
abdominal incision, the cecum was exposed and ligated
at approximately two-thirds of its length from the distal
tip, to maintain intestinal continuity. The cecum was
then punctured twice with a 22-gauge needle and a
small amount of its contents was expressed through the
punctures. A sham operation (laparotomy and exposure
of the cecum without any further manipulation) was
performed as a control. The incision was closed and 1 mL
of normal saline was administered subcutaneously. After
surgery, the animals had unrestricted access to food and
water. For mice that died during the night, the time of
death was recorded as the time at which they were
observed in the early morning. Samples were taken from
those that survived and the mice sacrificed at sampling
time points.
Time course after CLP challenge
Mice were divided into two groups and subjected to either
CLP or a sham operation (n = 5). Blood was obtained from
the inferior vena cava for platelet count, coagulation assay
and biomarker analysis at 0, 1, 2, 6, 12, 24, 48 or 72 h after
the treatment. They were then sacrificed and autopsied for
gross and microscopic evidence of DIC.
Blood chemistry
Blood samples were centrifuged at 3000 g for 10 min to ob-
tain serum. Alanine aminotransferase (ALT) and creatinine
were measured using an autoanalyzer (Sysmex DRI-CHEM
3500; Fuji, Japan).
Histology of lung and mesentery tissue
Lung and mesentery specimens were fixed in 10% buffered
formalin, processed by standard techniques and embedded
in paraffin. Cross-sectional cuts 3 μm thick were taken
from the middle zones of the lungs and mesenteries [27].
The sections were stained with hematoxylin and eosin for
histopathology and analysis of fibrin deposition, and exam-
ined with a light microscope (Zeiss Axioscop 40; Zeiss) by
a pathologist who was blinded to the experimental groups.
Ten high power fields were observed (×400), and digital
images were obtained with a digital camera (Nikon 4500;
Nikon Tokyo, Japan) and archived.
Coagulation assay
Prothrombin time (PT), activated partial thromboplastin
time (aPTT) and plasma fibrinogen were measured in an
automated coagulometer (Sysmex CA-7000; Fuji, Japan).
Platelet count was measured using an automatic blood
cell counter (Advia 2120; Siemens, Germany). D-dimer
was measured by enzyme-linked immunosorbent assay
(R&D Systems, USA).
Laboratory diagnosis of DIC in the mice [28] required













Figure 1 Survival rate after cecal ligation and puncture (CLP).
The CLP procedure resulted in significantly greater mortality than a
sham operation. CLP group, n = 20; sham group, n = 10. p < 0.01 vs.
sham group (Wilcoxon’s test).
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the upper limit of normal; (2) an absolute decrease in
plasma fibrinogen concentrations >25%; (3) an absolute
decrease in platelet count; and (4) positive hematoxylin
and eosin staining for intravascular fibrin formation on
post mortem tissue sections. Clinically, DIC in the mice
was recognized by spontaneous epistaxis and bleeding at
multiple sites and by evidence of gross internal hemorrhage
at autopsy.Figure 2 Blood markers of disseminated intravascular
coagulation in cecal ligation and puncture (CLP) group and
sham groups. *Significant difference compared with sham group
(n = 5, p < 0 .05).Flow cytometry
Platelet activity was assessed using platelet activation
markers (CD62P and CD63). Briefly, blood sample
containing sodium citrate was centrifuged for 15 minutes
at 1,500 rpm at room temperature. The samples were
incubated with saturating concentrations of phycoerythrin
(PE)-labeled antibodies (eBioscience, San Diego, CA, USA)
against CD62P and CD63 with fluorescein isothiocyanate-
labeled antibodies against CD61 for 30 minutes at room
temperature in the dark. For control experiments, platelets
were incubated with PE-coupled unspecific mouse IgG1
(eBioscience, San Diego, CA, USA) with the same ratio and
concentration of fluorochrome-to-protein as specific IgG.
After immuno-labeling, the samples were analyzed by
flow cytometry (BD FACSAria™, USA). Forward light
scatter and CD61 expression were used for platelet
identification. Platelet-bound anti-CD62P and anti-CD63
antibodies were determined by analyzing 10,000 platelets
for PE-positive fluorescence.
Figure 3 Blood chemistry in cecal ligation and puncture (CLP)
group and sham group. *Significant difference compared with




Figure 4 Histological changes in mouse lung and mesentery
tissue. Samples were obtained 6 h post-cecal ligation and puncture
(CLP) (hematoxylin and eosin; ×400). A: Mixed thrombus in lung
tissue 6 h post-CLP. B: Fibrin thrombus in mesentery tissue 6 h
post-CLP. C: Multiple thrombi in lung tissue 12 h post-CLP.
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assay
A custom mouse cytokine array kit (RayBiotech, USA)
was purchased. The array spotted the membrane with 50
specific antibodies against cytokines and chemokines per
our request. For the assay, we followed the instructions
precisely as stated by the manufacturer. Briefly, mem-
branes were placed in an eight-well tissue culture tray
and incubated with 2 mL of blocking buffer at room
temperature for 30 min. After decanting the blocking
buffer from each container, 1 mL of sputum supernatant
from the sample was added and incubated overnight at
4°C. After decanting the samples, all membranes were
washed three times with 2 mL of wash buffer I at room
temperature with shaking (5 min per wash), followed by
two washes with wash buffer II at room temperature
with shaking (5 min per wash). One milliliter of 1:250
diluted biotin-conjugated antibodies was prepared and
incubated for 2 h at room temperature, and the washing
steps were repeated as before. Two milliliters of 1:1000
diluted horse radish peroxidase-conjugated streptavidin
was added, and the membranes were incubated for 2 h
at room temperature, followed by additional washing.
Spots were visualized using detection buffer C and D.
Five hundred liters of a detection buffer C and 500 L of
detection buffer D were mixed, loaded onto the
membranes to cover the entire surface, and incubated
for 5 min. The membranes were then covered in plasticwrap and exposed to radiographic film (Kodak X-Omat;
Kodak; USA) for 20 min; the signal was detected using
film developer. Each film was scanned (CanoScan, Japan)
into an image-processing and analysis program (Image J,
NIH Image for Windows, version 1.44), and spots were
digitized into pixel densities. The densities were exported
Table 1 Histology for microthrombus formation in lung
and mesentery tissue from CLP and sham groups over
time (n = 5)
0 h 1 h 2 h 6 h 12 h 24 h 48 h 72 h
Sham group Lung 0 0 0 0 0 0 0 0
Mesentery 0 0 0 0 0 0 0 0
CLP group Lung 0 0 0 3* 5* 5* 5* 5*
Mesentery 0 0 0 2* 4* 5* 5* 5*
*Significant difference compared with sham group (n = 5, p < 0 .05).
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Microsoft Corp) and the background intensity was
deducted before analysis. The data were normalized to the
values for positive controls provided by the manufacturer
as 100%.
ELISA
Blood samples were kept standing for 15 min until coagula-
tion. After high-speed centrifugation (3000 rpm, 20 min),
the supernatant was collected, aliquoted and stored at
−70°C for analysis. The concentrations of thrombospondin
(TSP), tissue inhibitor of metalloproteinase 1 (TIMP-1) and
thymus chemokine-1 (TCK-1) were measured using spe-
cific ELISA kits (RayBiotech, USA) following the manufac-
turer’s protocols.Standard curves and regression equations
were calculated based on measurements of standard sam-
ples, and the cytokine concentrations in the serum samples
were calculated according to the regression equations.
Statistical analysis
Results are presented as the mean ± standard error of the
mean. When the data were normally distributed, Bartlett’s
test was used to test variance equality. Survival curve data











Figure 5 The percentage platelet surface expression of CD62P
and CD63 by flow cytometry in CLP group and sham group.
*Significant difference compared with sham group (n = 5, p < 0 .05).Wilcoxon’s test with SPSS 17.0 for Windows (SPSS Inc.,
IL, USA). Platelet count, blood chemistry findings, coagu-
lation assay results, platelet activity, biomarker analysis
and ELISA at various time points were compared between
the CLP and sham groups by analysis of variance using a
post hoc LSD method when the variances were equal. A
one-way approximate F test was used for comparison
when the variances were not equal. Lung and mesentery
histology data were analyzed using Fisher’s test. P-values
<0.05 were considered statistically significant.
Results
Mortality following CLP
Twenty mice subjected to CLP and ten sham mice were
observed for mortality. The survival rate at 72 h post-CLP
was 15%, but there was no mortality among the sham
mice (p < 0.01, Figure 1). This model was designed to
achieve a high incidence of DIC; thus, this high mortality
was expected.
Development of DIC
The CLP model successfully induced DIC, as shown by
changes in blood markers for DIC. Platelet count, PT,
aPTT, fibrinogen and D-dimer results are shown in Figure 2.
Compared with the sham group, the platelet count (n = 5,
p < 0.05) and fibrinogen concentration (n = 5, p < 0.05) of
the CLP group began to decrease significantly at 6 h
post-CLP. Significant prolongation of PT (n = 5, p < 0.05)
and aPTT (n = 5, p < 0.05) and elevation of D-dimer
(n = 5, p < 0.05) also occurred from 6 h after CLP.
Blood chemistry indicated that several organ damage
markers were elevated above the sham values, including
ALT and creatinine (Figure 3). The ALT of the CLP
group was increased significantly 6 h post-CLP compared
with the sham group (n = 5, p < 0.05). Significant elevation
of creatinine was observed in the CLP group 12 h post-CLP
(n = 5, p < 0.05). All of the above markers began to change
significantly at 6 h post-CLP.
Histology of lung and mesentery tissue
Histologic results for microthrombus formation in the
CLP and sham groups are shown in Figure 4 and Table 1.
In contrast to the sham group, neutrophil exudation and
tissue swelling had occurred in lung and mesentery tissue
1 h post-CLP, but microthrombus formation was not
detected (n = 5, p > 0.05). Signs of microthrombus had
appeared 6 h post-CLP, and became obvious and extensive
after 12 h (n = 5, p < 0.05). Simultaneously, alveolar con-
solidation, severe edema and tissue necrosis appeared.
There were no pathological changes in the sham group.
Platelet activation status assessment by flow cytometry
CD62P (P-selectin) is only expressed on the platelet surface
after dense granule secretion, and CD63 is expressed on
Table 2 Biotin label-based custom protein microarray map
A B C D E F G H I J K L M N
1 POS1 POS2 POS3 Blank neg neg Blank bFGF GM-CSF MMP-9 Blank IC-3 IC-2 IC-1
2 POS1 POS2 POS3 Blank neg neg Blank bFGF GM-CSF MMP-9 Blank IC-3 IC-2 IC-1
3 Blank Blank Blank TIMP-2 CCL-4 ICAM-2 Osteopo-rotegerin TIMP-4 CCL-7 IFN-gamma PDGF-C TLR-1 CCR-3 IFN-gamma R1
4 Blank Blank Blank TIMP-2 CCL-4 ICAM-2 Osteopo-rotegerin TIMP-4 CCL-7 IFN-gamma PDGF-C TLR-1 CCR-3 IFN-gamma R1
5 CCR-4 IGFBP-3 PDGF-R beta TLR-4 CD 11B IL-1 alpha PF-4 TPO CD 40 IL-2 RAGE TRAIL CD 40L IL-3
6 CCR-4 IGFBP-3 PDGF-R beta TLR-4 CD 11B IL-1 alpha PF-4 TPO CD 40 IL-2 RAGE TRAIL CD 40L IL-3
7 PDGF-R alpha TLR-2 RANTES TREM-1 CXCR-4 IL-7 SCF VEGF DKK-1 CD 18 TFPI Thymus
Chmokine-1
Endostatin Leptin
8 PDGF-R alpha TLR-2 RANTES TREM-1 CXCR-4 IL-7 SCF VEGF DKK-1 CD 18 TFPI Thymus
Chmokine-1
Endostatin Leptin
9 TGF-beta 1 Tissue Factor EPO LIGHT Thrombos-pondin G-CSF MMP-2 TIMP-1 Blank Blank Blank POS 6 POS 5 POS 4
10 TGF-beta 1 Tissue Factor EPO LIGHT Thrombos-pondin G-CSF MMP-2 TIMP-1 Blank Blank Blank POS 6 POS 5 POS 4



















Figure 6 Custom protein microarray analysis in cecal ligation
and puncture (CLP) group and sham group. A: Sham group.
B: 1 h post-CLP group. C: 2 h post-CLP group. D: 6 h post-CLP
group. E: 12 h post-CLP group. F: 24 h post-CLP group. G: 48 h
post-CLP group. H: 72 h post-CLP group.
Figure 7 Protein microarray signal intensities of TSP, PF4,
TIMP-1 and TCK-1 in cecal ligation and puncture (CLP) group
and sham group. *Significant difference compared with sham
group (n = 5, p < 0.05).
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granules.So the percentage platelet surface expression of
CD62P and CD63 are always quantified by flow cytometry
to assess platelet activation status. In contrast to the sham
group, the percentage platelet surface expression of CD62P
and CD63 were significantly higher 2 h post-CLP (n = 5,
p < 0.05, Figure 5).
Protein microarray analysis
Given the importance of platelets in coagulation and as
immune mediators, platelet-derived factors were chosen
as biomarkers of the early stage of sepsis-induced DIC.
To identify valuable diagnostic biomarkers, fifty platelet-
secreted factors were selected for the custom biotin
label-based mouse cytokine microarray assay kit. The
name and location of each custom cytokine or chemo-
kine spot are listed in Table 2. Based on the results ofthe coagulation assay, 6 h post-CLP was regarded as the
early stage of sepsis-induced DIC.
Compared with the sham group, thrombospondin (TSP)
(E9, E10), platelet factor 4 (PF4) (G5, G6) and tissue
inhibitor of metalloproteinase 1 (TIMP-1) (H9, H10) were
obviously increased 1 h post-CLP (Figure 6A, Figure 6B).
Figure 8 Serum concentrations of TSP, TIMP-1 and TCK-1 in cecal
ligation and puncture (CLP) group and sham group by ELISA.
*Significant difference compared with sham group (n = 5, p < 0.05).
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post-CLP (Figure 6C), granulocyte colony-stimulating
factor (G-CSF) (F9, F10) had appeared 6 h post-CLP and
C-X-C chemokine receptor type 4 (CXCR4) (E7, E8) had
appeared 24 h post-CLP (Figure 6F). Therefore, TSP, PF4,
TIMP-1and TCK-1 warrant evaluation as biomarkers of
the early stage of sepsis-induced DIC.
The protein microarray signal intensities of these cyto-
kines and chemokines over time are summarized in
Figure 7. TSP levels in the CLP group increased and
peaked sharply at 1h post-CLP; they then decreased
gradually until 72 h post-CLP, but remained significantly
higher than in the sham group (n = 5, p < 0.05). PF4
levels in the CLP group were increased 1 h post-CLP,
peaked at 2 h post-CLP (n = 5, p < 0.05), then decreased
rapidly to the level of the sham group (n = 5, p > 0.05).
TIMP-1 levels were also increased 1 h post-CLP, then
continued to increase in the CLP group (n = 5, p < 0.05).
TCK-1 levels in the CLP group were significantly
increased 2 h post-CLP and remained higher than in
the sham group until 72 h post-CLP (n = 5, p < 0.05).
Somewhat differently, the serum levels of TIMP-1
measured by ELISA were also increased 2 h post-CLP
significantly (n = 5, p < 0.05). Nevertheless, the serum
levels of TSP, TIMP-1 and TCK-1 measured by ELISA
have the similar change with the protein microarray
signal intensities analysis (n = 5, p < 0.05, Figure 8).Discussion
As one of the most severe complications of sepsis, DIC
is always associated with poor prognosis, multiply organ
dysfunction and high mortality. Generally, clinical diag-
nosis of DIC relies on platelet count, coagulation assay,
d-dimer and fibrinogen. However, when the results of
such tests are positive, the best time for treatment had
already passed. In much basic research, the difficulty of
early prediction of sepsis-induced DIC is related to the
large number of coagulation factors, chemokines and
cytokines, and their complicated interactions. Platelet-
derived factors are distinct from others because of their
role at the crossroads of coagulation and inflammatory
pathways such as the complement, contact phase, coagula-
tion and fibrinolytic systems, host defense and antibacterial
action [29,30]. Protein microarray technology allows us to
study many molecules simultaneously and elucidate their
interactions. A protein-detecting microarray comprises
many different affinity reagents arrayed at high density.
Each agent captures a target protein from a complex
mixture, and the captured proteins are subsequently
detected and quantified [31,32]. For the present study, a
protein microarray kit was customized to serially detect
fifty platelet-secreted factors in a mouse CLP model.
The CLP model imitates sepsis by creating a bowel
perforation with leakage of fecal material into the
peritoneal cavity. Since it was modified and popularized
by Wichterman in 1980 [33], the CLP model has been
considered the gold standard for sepsis research.
Initially, CLP was not as widely used as lipopolysaccharide
(LPS) as an inducer of DIC in animal models, probably
because of its low reproducibility [34-36]. However, since
its standardization by Rittirsch in 2009 [26], it has been
possible to reproduce CLP exactly. Moreover, animals
subjected to CLP simulate a true infectious septic state,
and the decreased cardiovascular function and cardiac
output induced by LPS are avoided [37]. In the CLP
procedure used in the present study, the large ligation and
needle size were necessary for high grade sepsis-induced
DIC, and ensured 85% mortality at 72 h post-procedure.
Development of DIC in the experimental mice was
confirmed by the decreased platelet count and fibrinogen
concentration, the prolongation of PT and aPTT, the
elevation of D-dimer and the autopsy evidence of throm-
bosis in end-organs. The evolution of multiple organ
dysfunction was corroborated by the increased ALT and
creatinine. Six hours post-CLP was identified as the early
stage of sepsis-induced DIC in the model, because all
significant changes in clinical markers had occurred by
this time. CD63 and CD62P (p-selectin) [38] are expressed
on the platelet surface [39] and secreted into plasma [40]
when platelets become activated. In resting platelets CD63
is stored in lysosomes and CD62P in a-granule. Therefore,
the percentage platelet surface expression of CD62P and
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higher 2 h post-CLP. Simultaneously, the platelet-secreted
factors TSP, PF4, TIMP-1 and TCK-1 changed significantly
during the first 6 h post-CLP and were therefore regarded
as meaningful biomarkers of the early stage of sepsis-
induced DIC. G-CSF and CXCR4 were excluded because
their levels in the experimental mice began to differ
significantly after 6 h post-CLP.
TSP was first isolated from platelets that had been
stimulated with thrombin, and was designated as a
matricellular glycoprotein with multiple functions in many
biological processes including angiogenesis, apoptosis and
immune regulation [41,42]. PF4, also known as chemokine
C-X-C motif ligand 4, is released from activated plate-
lets during platelet aggregation and promotes blood
coagulation [43]. TIMP-1, as natural inhibitor of matrix
metalloproteinases has been shown to be involved in
degradation of the extracellular matrix and to have an
effect on the fibrinolytic system [44]. TCK-1 belongs to
the family of CXC chemokines and has been shown to
be a chemoattractant for pro-B cells engineered to
express the CXCR2 receptor [45]. In the early stage of
the mouse CLP model, TSP, PF4, TIMP-1and TCK-1
levels exhibited differing trends on protein microarray
analysis. PF4 levels in the CLP group peaked 2 h post-
CLP and decreased rapidly to the level of the sham
group, which would made it difficult to capture abnor-
mal PF4 levels in clinical practice. TSP levels in the CLP
group increased and peaked sharply at 1 h post-CLP,
then decreased but remained significantly higher than
in the sham group. Both TIMP-1 and TCK-1 increased
within 2 h post-CLP, then remained at higher levels
than in the sham group until 72 h post-CLP. The long
duration of the significant difference between experi-
mental animals and controls indicates that TSP, TIMP-
1and TCK-1 might be used to predict sepsis-induced
DIC. The serum levels of TSP, TIMP-1 and TCK-1 mea-
sured by ELISA have proved that again.
Although elevations in cytokines/chemokines and
their correlation with sepsis-induced DIC are meaning-
ful observations, their relevance to the cause of DIC
remains unclear. Further clinical trials will be required
to validate the usefulness of TSP, TIMP-1 and TCK-1
in patients.Conclusions
We have demonstrated the development of DIC in
experimental mice by means of decreased platelet count
and fibrinogen concentration, prolongation of PT and
aPTT, elevations of D-dimer and autopsy evidence of
thrombosis in end-organs. By protein microarray analysis,
we have identified TSP, TIMP-1and TCK-1 as biomarkers
predictive of the early stage of sepsis-induced DIC.Abbreviations
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